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Isoflurane alters proximal tubular cell susceptibility to
toxic and hypoxic forms of attack
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The Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, Washington, USA
Isoflurane alters proximal tubular cell susceptibility to toxic and it is surprising that almost no studies have examined the
hypoxic forms of attack. impact of fluorinated anesthetics on the expression of
Background. Fluorinated anesthetics can profoundly alter plasma
acute ischemic and toxic renal tubular damage. This ismembrane structure and function, potentially impacting cell injury
responses. Because major surgery often precipitates acute renal failure, despite the fact that hypotension/renal hypoperfusion
this study assessed whether the most commonly used fluorinated anes- and nephrotoxin exposures (for example, to aminoglyco-
thetic, isoflurane, alters tubular cell responses to toxic and hypoxic attack.
sides, radiocontrast agents, and myoglobinuria) are com-Methods. Mouse proximal tubule segments were incubated under
control conditions or with a clinically relevant isoflurane dose. Cell mon during the immediate preoperative and intraopera-
viability (lactate dehydrogenase release), deacylation (fatty acid, such tive periods.
as C20:4 levels), and adenosine triphosphate (ATP) concentrations
Several pieces of evidence strongly suggest that fluo-were assessed under one or more of the following conditions: (a)
exogenous phospholipase A2 (PLA2) or C20:4 addition, (b) Ca21 over- rinated anesthetics might indeed influence the induction
load (A23187 ionophore), (c) increased metabolic work (Na ionophore), of ARF. First, inorganic fluoride, a by-product of cyto-
and (d) hypoxia- or antimycin A–induced attack. Isoflurane’s effect
chrome p-450 mediated fluorinated anesthetic metabo-on NBD phosphatidylserine uptake (an index of plasma membrane
lism [2], can exert direct in vivo and in vitro tubulotoxicaminophospholipid translocase activity) was also assessed.
Results. Isoflurane alone caused trivial deacylation and no lactate effects [4–7]. Second, methoxyflurane, a highly defluori-
dehydrogenase release. However, it strikingly sensitized to both PLA2- nated anesthetic, caused multiple cases of ARF duringand A23187-induced deacylation and cell death. Isoflurane also exacer-
the 1960s and 1970s, leading to its clinical abandonmentbated C20:4’s direct membrane lytic effect. Under conditions of mild
ATP depletion (Na ionophore–induced increased ATP consumption; [8–10]. Third, we have previously documented that high
PLA2-induced mitochondrial suppression), isoflurane provoked mod- concentrations of currently used fluorinated anestheticserate/severe ATP reductions and cell death. Conversely, under con-
(isoflurane, sevoflurane, desflurane) can induce lethalditions of maximal ATP depletion (hypoxia, antimycin), isoflurane
conferred a modest cytoprotective effect. Isoflurane blocked amino- cell injury in isolated rat proximal tubular segments
phospholipid translocase activity, which normally maintains plasma (PTS) [11]. The potential clinical relevance of the lattermembrane lipid asymmetry (that is, preventing its “flip flop”).
finding was suggested by further observations that (a)Conclusions. Isoflurane profoundly and differentially affects tubular
cell responses to toxic and hypoxic attack. Direct drug-induced alter- isoflurane, a widely used agent, was approximately 50%
ations in lipid trafficking/plasma membrane orientation and in cell as toxic as methoxyflurane (which caused clinical ARF);energy production are likely involved. Although the in vivo relevance
(b) when applied in a pharmacologically relevant dose,of these findings remains unknown, they have potential implications
for intraoperative renal tubular cell structure/function and how cells isoflurane impaired tubule energetics; and (c) isoflurane
may respond to superimposed attack. anesthesia seemingly induced proximal tubular enzymu-
ria in surgical patients [11]. In a second series of experi-
ments [12], fluorinated anesthetics stimulated in vivo and
Over the past 40 years, fluorinated hydrocarbons, such in vitro renal cortical sphingomyelin hydrolysis (denoted
as isoflurane, halothane, and enflurane, have remained by increments in ceramide and sphingosine, sphingomye-
mainstays of inhalational anesthesia [1, 2]. Currently, lin-derived signaling molecules). These latter observa-
approximately 25-million patient exposures occur annu- tions, coupled with findings that clinically relevant doses
ally. The perioperative period remains a common time of fluorinated anesthetics increase membrane fluidity
for the onset of acute renal failure (ARF) [3]. Therefore, (assessed with neuroneal micelles) [13, 14], indicate that
these agents can profoundly impact cell membrane ho-
meostasis. Thus, altered cellular responses to superim-Key words: acute renal failure, phospholipase A, adenosine triphos-
phate, lactate dehydrogenase, free fatty acid, red blood cells. posed ischemic and toxic attack might also result.
In light of these considerations, this study was under-Received for publication June 23, 1998
taken to characterize the influence of fluorinated anes-and in revised form August 3, 1998
Accepted for publication August 4, 1998 thetics on the expression of selected forms of superim-
posed acute proximal renal tubular damage. Because 1999 by the International Society of Nephrology
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isoflurane is currently the most widely used fluorinated Isoflurane additions to PTS
anesthetic [2], it was selected as the test agent. Because All experiments employing isoflurane additions were
general anesthesia alters systemic/renal hemodynamics conducted by injecting 3.75 ml of liquid isoflurane (Fu-
[2], isolated proximal tubules were used for most of these rane; Ohmeda, Liberty Corner, NJ, USA) into the 30
experiments in order to gauge direct tubular cell effects. ml Erlenmeyer flasks that had been tightly sealed with
The following specific questions were addressed: (a) Be- rubber stoppers (to prevent isoflurane loss following its
cause fluorinated anesthetics can alter membrane ho- rapid vaporization). This amount of isoflurane was cho-
meostasis (for example, fluidity and sphingomyelin hy- sen to simulate a pharmacologically relevant dose. This
drolysis), could isoflurane also impact plasma membrane was based on the following three pieces of information:
responses to phospholipase A2 (PLA2) and arachidonic First, this dose induces an isoflurane gas space concentra-
acid (C20:4)-mediated attack? The relevance of this
tion of 2.2%, as determined by gas chromatographyquestion stems from observations that both PLA2 and (E.D. Kharasch, personal communication). This equatesC20:4 can be critical determinants of ischemic/toxic tubu-
to an anesthetic dosage of 1.8 MAC (where 1 MAC, orlar cell death [15–18]. (b) Because fluoride can cause cell
“minimum alveolar concentration,” is the percentage ofCa21 loading, and change intracellular Ca21 distribution
inhaled anesthetic that immobilizes 50% of humans/ani-[19–21], could isoflurane alter the expression of Ca21-
mals subjected to noxious stimuli). (Following an equili-mediated cytotoxicity? (c) Because we previously ob-
bration period during surgery, anesthetic concentrationsserved that fluorinated anesthetics can impair mitochon-
in alveoli, whole blood, and tissue water approach unitydrial adenosine triphosphate (ATP) production [11], the
[1, 2].) Second, pilot data indicated that, as in humans,question was, could isoflurane predispose tubular cells
1.8 MAC isoflurane produces deep, but reversible, anes-to energy depletion forms of attack?
thesia in male CD-1 mice (the source of the employed
PTS), and third, it has previously been demonstrated by
METHODS gas chromatography [11] that the employed isoflurane
Isolated proximal tubule segment preparations dose produces pharmacologically relevant PTS fluid con-
centrations (approximately 0.9 mmol/ml).Male CD-1 mice, weighing 25 to 50 g (Charles River
Laboratories, Wilmington, MA, USA) and maintained
Isoflurane effects on exogenous PLA2 toxicityunder normal laboratory conditions, were used to pre-
pare isolated PTS. The mice were anesthetized with ap- Lethal cell injury. The following experiment assessed
proximately 2 mg intraperitoneal pentobarbital. The kid- the impact of isoflurane exposure on how PTS respond
neys were removed through a midline abdominal incision to exogenous PLA2 attack. Six sets of PTS were pre-
immediately following induction of anesthesia, and then pared. Each was divided into six aliquots, and they were
PTS were prepared by a previously described technique incubated as follows: (a) control condition, (b) isoflurane
[11, 18]. In brief, following resection, the kidneys were exposure, (c) 5 units/ml PLA2 (from porcine pancreas;
cooled on an ice plate, and the cortices were dissected. P-6534; Sigma Chemicals, St. Louis, MO, USA), (d) 10
They were minced with a razor blade, digested with units/ml PLA2, (e) isoflurane 1 5 units/ml PLA2, and ( f)
collagenase, passed through a stainless steel sieve, and isoflurane 1 10 units/ml PLA2. After completing the 60
then pelleted by centrifugation (48C). Viable PTS were minute incubations, cell injury/loss of plasma membrane
recovered by centrifugation through 32% Percoll (Phar- integrity was assessed by calculating the percentage of
macia, Piscataway, NJ, USA). After multiple washings lactate dehydrogenase (LDH) release [18]. Since pancre-
in iced buffer, the PTS were suspended (approximately atic PLA2 penetrates plasma membranes, gaining inner2 to 4 mg PTS protein/ml) in experimentation buffer (in
membrane leaflet access [22], its action following themmol/liter: NaCl, 100; KCl, 2.1; NaHCO3 25; KH2PO4, addition to cell suspensions cannot simply be ascribed2.4; MgSO4 1.2; MgCl2, 1.2; CaCl2, 1.2; glucose, 5; alanine, to a direct action on the outer plasma membrane.1; Na lactate, 4; Na butyrate 10; 36 kD dextran, 0.6%)
Isoflurane effects on PLA2-mediated tubule deacylation.and were gassed with 95% O2/5% CO2; final pH, 7.4).
Four sets of PTS were prepared, and each was dividedThey were rewarmed to 378C in a heated shaking water
into four equal aliquots as follows: (a) control incubation,bath over 15 minutes, and then the PTS preparations
(b) incubation with isoflurane, (c) incubation with 5 units/were divided into four to six equal aliquots, depending
ml PLA2, and (d) incubation with 5 units/ml PLA2 1on the particular experiment (2.5 ml of PTS suspension
isoflurane. After 30-minute incubations (not 60 minutesplaced into 30 ml Erlenmeyer flasks). Specific protocols
as done above to mitigate differences in cell death), anare described in the sections later here. When experi-
aliquot from each flask was saved to determine percent-ments required six PTS aliquots, renal tissues from two
age LDH release, and then the PTS aliquots were imme-mice were combined for PTS extraction. When less than
diately extracted in chloroform:methanol (1:2) to assesssix aliquots were required, tissue from a single mouse
was used. “free” fatty acid (FFA) levels. FFAs (C16:0, C18:0, C18:1,
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C18:2, C18:3, C20:4, C22:6) were analyzed as previously control conditions, (b) isoflurane exposure, (c) 35 mm
A23187, and (d) isoflurane plus 35 mm A23187. Afterreported [23], with the exception that the FFAs were
separated from other lipids by thin layer chromatography completing 30-minute incubations, samples from each
aliquot were saved to calculate the percentage LDHusing chloroform:acetic acid:methanol (94:5:1 by vol).
The FFA were extracted from the silica with chloroform: release, and then the remaining tubules were analyzed
for FFA, as noted earlier in this article. Samples weremethanol (2:1) [24, 25]. The recovered fatty acids were
then derivatized and quantitated by high pressure liquid analyzed after 30-minute, rather than 60-minute, incuba-
tions to minimize differences in cell death (which canchromatography (HPLC), as previously described [23].
nonspecifically impact FFA accumulation).
Isoflurane effects on arachidonic acid (C20:4)
cytotoxicity Effect of isoflurane on amphotericin B–mediated
cytotoxicityBecause isoflurane potentiated PLA2 cytotoxicity (Re-
sults section), the following experiment assessed whether The following experiment analyzed whether isoflurane’s
previously documented negative influence on mitochon-this could be attributed, at least in part, to cytotoxic fatty
acid accumulation. Six sets of PTS were each divided drial function [11] could alter cell injury under conditions
of increased ATP demand. To make this assessment,into four aliquots and were incubated as follows: (a)
control conditions, (b) with isoflurane, (c) with a suble- four sets of PTS were each divided into six equal aliquots
as follows: (a) control incubation, (b) isoflurane expo-thal C20:4 dose (50 mm; Sigma Chemicals; added in etha-
nol, 0.1% final concentration), and (d) with isoflurane 1 sure, (c) addition of a sodium ionophore [amphotericin
B (AB), 25 mg/ml; Pharmacia, Albuquerque, NM, USA],50 mm C20:4. At the end of the 60 minute exposures, the
percentage LDH release was assessed. (d) AB, 50 mg/ml, (e) isoflurane plus 25 mg/ml AB, and
( f) isoflurane plus 50 mg/ml AB. After completing theTo explore this issue further, four additional PTS prep-
arations were treated exactly as mentioned earlier in our 60-minute incubations, samples from each flask were
saved to calculate the percentage LDH release. The re-study, except that an overtly cytotoxic C20:4 dose (200
mm) was employed. Cell injury was, once again, assessed mainder of the samples were immediately analyzed for
ATP, ADP, and AMP as noted earlier here.by LDH release.
Impact of isoflurane on PLA2/C20:4-mediated changes Effect of isoflurane on hypoxic proximal tubular injury
in cellular energetics Six sets of PTS were divided into four aliquots and
were incubated as follows: (a) control incubation 3 60Phospholipase A2 can suppress mitochondrial ATP
production, an effect specifically attributable to PLA2- minutes, (b) incubation with isoflurane 3 60 minutes,
(c) control incubation 3 45 minutes, followed by 15 min-mediated C20:4 release [18]. The following experiment
was undertaken to determine the impact of isoflurane utes of hypoxia, and (d) incubation with isoflurane 3 45
minutes, followed by 15 minutes of hypoxia. Hypoxiaexposure on these PLA2/C20:4-mediated changes in cel-
lular energetics. Four sets of PTS were each divided was created by displacing the 95% O2/5% CO2 (and the
vaporized isoflurane) in each of the flasks by gassinginto four aliquots as follows: (a) control incubation, (b)
isoflurane exposure, (c) five units/ml PLA2, (d) 50 mm with 95% N2/5% CO2. This was done by inserting two
needles into the rubber stopper: one for N2/CO2 deliveryC20:4, (e) PLA2 plus isoflurane, ( f) C20:4 plus isoflurane.
After 30-minute incubations, tubule aliquots were saved and one permitting gas efflux. After completing the re-
gassing, the needles were withdrawn for the remainderfor LDH release assessments, and then the remainder
of the samples was extracted and analyzed for adenine of the hypoxic period. Cell injury (percentage LDH re-
lease) was assessed at the completion of the 60-minutenucleotide (ATP, ADP, AMP) content, as previously
described [18]. incubations.
Effect of isoflurane on antimycin A–mediatedEffect of isoflurane on Ca21 ionophore-mediated
cell injury cytotoxicity
Lethal cell injury. Induction of hypoxia in the pre-Lethal cell injury. Six sets of PTS were each divided
into four aliquots as follows: (a) control incubation, (b) viously mentioned experiment resulted in the simultane-
ous evacuation of the vaporized isoflurane. Thus, mini-isoflurane treatment, (c) addition of Ca21 ionophore
A23187, and (d) Ca21 ionophore plus isoflurane. A23187 mal, if any, isoflurane was present during the period of
hypoxic ATP depletion. The following experiment waswas applied in either 35 or 50 mm concentrations (three
sets of tubules with each dose). After completing 60- undertaken to determine the impact of isoflurane on
PTS viability when the drug was present during ATPminute incubations, the percentage LDH release was
determined. depletion. Six sets of PTS were divided into four equal
aliquots as follows: (a) control incubation 3 60 minutes,Degrees of deacylation. Four sets of PTS were divided
into four aliquots and were incubated as follows: (a) (b) isoflurane exposure alone 3 60 minutes, (c) control
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incubation 3 45 minutes, followed by a 15-minute expo- Isoflurane’s impact on aminophospholipid transport
sure to antimycin A, a mitochondrial respiratory chain Aminophospholipid translocase(s) is critical to main-
inhibitor (7.5 mm; injected through the rubber stopper), taining normal phospholipid asymmetry across the plasma
and (d) isoflurane exposure 3 60 minutes, with antimycin membrane [28–30]. Because this process is an important
A treatment during the last 15 minutes of the incubation. determinant of membrane function, and presumably
At the end of these 60-minute incubations, the percent- membrane/cell injury responses, and because inorganic
age LDH release was determined. fluoride inhibits this transport system, the impact of
Degrees of deacylation during ATP depletion injury. isoflurane on it was assessed. Cultured human proximal
To determine the impact of isoflurane on degrees of tubular cells were grown to confluence in T-25 flasks, as
deacylation induced during ATP depletion injury, four previously described [31]. The flasks were then sealed
of the sets of PTS that had been subjected to the anti- with rubber stoppers and exposed to either the standard
mycin A/isoflurane protocol underwent lipid extraction isoflurane dose 3 30 minutes (which induces no cell
and FFA analysis. To assess the impact of isoflurane on death) or to continued control incubation conditions.
ATP depletion-mediated deacylation in the absence of Then a 2.5 mm lipid suspension [80% phosphatidylcholine
cell death, four additional sets of PTS were each divided (Sigma P-7763)/20% NBD-phosphatidylserine (810194;
into four aliquots. Two mm glycine were added to each
Avanti Polar Lipids, Alabaster, AL, USA)] was addedaliquot (a well characterized cytoprotectant) [26, 27],
through the rubber stopper (final lipid concentration,and then the flasks were incubated as follows: (a) control
100 mm). Cell uptake of the NBD-phosphatidylserine, aincubation 3 60 minutes, (b) isoflurane exposure 3 60
marker of aminophospholipid transferase activity [32],minutes, (c) control incubation 3 45 minutes, followed
was assessed semiquantitatively within five minutes byby 15-minute antimycin A exposure, and (d) isoflurane
fluorescence microscopy. India ink (200 ml) was addedexposure 3 60 minutes, with antimycin A present during
to the flasks to quench background fluorescence.the final 15 minutes. After completing these 60-minute
incubations, the percentage LDH release and FFA gen- Calculations and statistics
eration was assessed.
All values are presented as means 6 1 sem. Statistical
comparisons were performed by either paired or un-Effect of glycine on the expression of
paired Student’s t-test, as appropriate. If multiple com-isoflurane cytotoxicity
parisons were made, the Bonferroni correction was ap-The following experiment assessed whether glycine
plied. FFA levels were expressed as pmol/nmol totalcan attenuate isoflurane’s tubulotoxic effects. Towards
phospholipid phosphate, the latter determined by thethis end, four sets of PTS were each divided into three
method of Van Veldhoven and Mannaerts [33]. For easealiquots and were incubated 3 60 minutes as follows:
of reporting, total unsaturated and total saturated FFAs(a) control conditions, (b) exposure to an overtly toxic
are presented. Because C20:4 release is the most specificisoflurane dose (10 ml, rather than the usual 3.75 ml) [11],
marker of PLA2-mediated deacylation, it is presentedand (c) 10 ml isoflurane exposure plus 2 mm glycine. Cell
independently. Adenine nucleotides were expressed asinjury was then assessed by calculating the percentage
nmol/mg PTS protein.of LDH release.
Isoflurane effects on red blood cell susceptibility to
RESULTSC20:4 attack
Isoflurane effects on PLA2 toxicityThis experiment was undertaken to determine whether
Lethal cell injury. PLA2 induced dose-dependent PTSisoflurane’s ability to affect cell injury could only be
cytotoxicity (0, 5, 10 units/ml PLA2: 15%, 19%, 33%expressed in PTS (for example, could PTS isolation in-
LDH release; Fig. 1). Isoflurane did not have any inde-jury be a prerequisite for isoflurane’s actions?). Mice
pendent effect on LDH release (15% without or withwere anesthetized with pentobarbital. They were phle-
isoflurane). However, isoflurane dramatically sensitizedbotomized from the inferior vena cava using heparinized
the PTS to PLA2’s cytotoxic effect, causing approxi-syringes. The red blood cells (RBCs) were pelleted by
mately 50% and 100% increases in the percentage LDHcentrifugation, and then the packed cells (approximately
release with the 10 units/ml and 5 units/ml PLA2 chal-1 ml) were washed twice in PTS buffer. The RBCs were
lenges, respectively (Fig. 1).diluted 1:35 in PTS buffer; 2.5 ml aliquots were added
Independent effects of isoflurane on PTS FFA lev-to the Erlenmeyer flasks, and they were incubated (378C)
els. As shown in Figure 2, in the absence of any otherwith either 0, 50, 100, or 200 mm C20:4 additions. Parallel
challenges, isoflurane caused quantitatively trivial, butincubations were conducted, except for concomitant
statistically significant, FFA increments. For example,isoflurane exposure, as noted earlier here (N 5 4 sepa-
isoflurane only raised C20:4 levels by approximately 0.4rate parallel experiments). RBC injury was assessed after
30 minutes by the percentage LDH release. pmol/nmol phosphate.
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Fig. 1. Effect of isoflurane (Iso) on cell viability (% LDH release)
after 60-minute incubations in the absence or presence of exogenous Fig. 3. Free fatty acid levels in control and isoflurane (Iso) exposed
PLA2 (5 or 10 units/ml). Isoflurane had no independent effect on cell tubules after completing 30-minute incubations with 5 units/ml of exoge-
viability, but it substantially enhanced tubule susceptibility to PLA2’s nous PLA2. The extent of PLA2 induced deacylation was markedly
cytotoxic effect. *P , 0.04; #P , 0.01. increased by the presence of isoflurane (indicating that isoflurane mark-
edly increased tubule susceptibility to PLA2 attack). Abbreviations as
per Fig. 2. Since these assessments were made after 30 min incubations,
they preceded significant differences in tubule cell death (between 12%
and 23% LDH release). *P , 0.025; #P , 0.05; †P , 0.10.
Fig. 2. Free fatty acid levels in tubules under control conditions and
with isoflurane (Iso) exposure. C20:4 is arachidonic acid. For ease of Fig. 4. Isoflurane (Iso) effects on tubule vulnerability to exogenous
data presentation, the remainder of the fatty acid data are presented C20:4 attack. Isoflurane predisposed to both 50 and 100 mm C20:4
as either total unsaturated fatty acids [unsat’d (t) 5 C22:6 1 C20:4 1 mediated cell lysis (LDH release), as assessed after 60-minute incuba-
C18:1 1 C18:2 1 C18:3] or total saturated fatty acids [sat’d (t) 5 16:0 1 tions. Isoflurane did not independently affect cell viability. *P , 0.01;
C18:0]. Although isoflurane induced significant fatty acid increments, #P , 0.02.
they were quantitatively trivial (note the different scales used in the
figures presenting fatty acid data). *P , 0.02; #P , 0.03.
exacerbate C20:4 toxicity was also observed when C20:4
was added in an overtly cytotoxic concentration (200 mm;Phospholipase A2-mediated deacylation. As expected,
Fig. 4). As previously noted, the employed isofluranePLA2 induced dramatic deacylation (Fig. 3), raising un-
dose did not independently alter the percentage LDHsaturated FFA approximately 25-fold and saturated FFA
release.approximately eightfold over control values (which are
depicted in Fig. 2). Despite the fact that isoflurane had
Effect of isoflurane on PLA2/C20:4-induced changes inan extremely minimal independent effect on tubule FFA
cellular energeticslevels, it dramatically potentiated PLA2’s deacylation ef-
In the absence of other challenges, PLA2 and C20:4fect (Fig. 3). For example, PLA2 generated approxi-
reduced ATP levels by approximately 20% and 10%,mately 10 and 80 pmol/nmol of C20:4 in absence and
respectively, which is consistent with previously reportedpresence of isoflurane, respectively.
data (Fig. 5), [18]. Isoflurane also caused modest ATP
Isoflurane effects on C20:4 toxicity declines (Fig. 5, left). When isoflurane was present with
either PLA2 or C20:4, synergistic ATP depressions wereThe addition of 50 mm C20:4 to PTS did not increase
apparent (Fig. 5). These were paralleled by comparablethe percentage LDH release above control values. How-
declines in total adenine nucleotide (ATP 1 ADP 1ever, in the presence of isoflurane, C20:4 induced a sig-
nificant cytotoxic effect (Fig. 4). Isoflurane’s ability to AMP) content (not depicted). Because these adenine
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Degrees of deacylation. The results of FFA analysis
performed after 30 minutes of 35 mm Ca21 ionophore
exposure are presented in Figure 7. Ca21 ionophore most
prominently affected the C20:4 concentrations, raising
them approximately threefold over control values. This
C20:4 accumulation was approximately tripled again in
the presence of isoflurane (Fig. 7A). Parallel changes in
total unsaturated and total saturated FFA pools were
also apparent (Fig. 7 B, C).
Isoflurane effects on the expression of AB toxicity
Lethal injury. As shown in Figure 8, the addition of
AB to control tubules caused either no or minimal incre-
Fig. 5. Effects of isoflurane (Iso), PLA2 (5 units/ml), and C20:4 (50 mM) ments in LDH release (0, 25, 50 mg/ml AB: 15%, 15%,on tubule ATP concentrations. After completing 30-minute incubations,
and 19%, respectively). Conversely, when either 25 orIso, PLA2, and C20:4 each induced mild reductions in tubule ATP
levels. However, when present together, PLA2/Iso and C20:4/Iso induced 50 mg/ml AB was added in the presence of isoflurane,
marked, synergistic ATP decrements. *P , 0.005; #P , 0.02; †P , marked and statistically significant increments in LDH0.001.
release resulted (Fig. 8; *P , 0.001 vs. AB alone). As
previously noted, isoflurane had no independent effect
on LDH release.
Adenosine triphosphate assessments. Isoflurane and
AB each independently induced approximately 33% re-
ductions in tubule ATP concentrations (Fig. 9). When iso-
flurane and AB were present together, approximately 90%
ATP depressions resulted (indicating synergistic impair-
ment of cellular energetics). Synergistic declines in total
adenine nucleotide content also resulted (not shown).
Isoflurane effects on hypoxic/antimycin A-mediated
injury
Lethal cell injury. Fifteen minutes of hypoxia induced
48% 6 3% LDH release (Fig. 10A). Pretreatment with
isoflurane induced a modest, but highly significant, cyto-
protective effect (39% 6 3%; P , 0.005). When ATPFig. 6. Effect of isoflurane (Iso) on Ca21 ionophore A23187 (CaI)–
depletion was induced by antimycin A, rather than hyp-induced cell death (LDH release). CaI cytotoxicity was dose dependent,
and at both the 35 and 50 mm doses, the extent of cell death was oxia (permitting the isoflurane to be present during the
significantly increased by concomitant isoflurane exposure. Isoflurane ATP depletion period; Methods section), the same de-did not independently affect LDH release. *P , 0.01; #P , 0.04.
gree of isoflurane-mediated cytoprotection was observed
(Fig. 10B).
Degrees of deacylation. Antimycin A induced the ex-
pected increments in FFA concentrations (Fig. 11A).nucleotide assessments were made after 30 minutes
(rather than the usual 60-min incubations, as explained Despite isoflurane’s ability to enhance deacylation in the
presence of PLA2 or Ca21 ionophore (Figs. 3 and 7), itearlier), only modest increments in the percentage of
LDH release were apparent (between 15% and 25%; had no effect on antimycin A–induced deacylation. This
was not simply due to an isoflurane-mediated decline indata not shown).
cell death (LDH release), as glycine completely abro-
Isoflurane effects on Ca21 ionophore-mediated injury gated antimycin-induced cell killing (13% to 15% LDH
release), and yet isoflurane did not alter the antimycin-Lethal cell injury. As shown in Figure 6, 60-minute ex-
posures to A23187 Ca21 ionophore induced dose-depen- induced FFA increments (Fig. 11B).
dent cytotoxicity (0, 35, 50 mm had approximately an 18%,
Impact of isoflurane on RBC susceptibility to36%, 50% LDH release, respectively). Whereas isoflurane
C20:4-mediated attackinduced no independent cytotoxicity, it significantly in-
creased the extent of Ca21 ionophore-induced cell death. Isoflurane had no independent effect on RBC integ-
rity, as assessed by LDH release (3% 6 0.5% whetherThis was observed at both the 35 mm and 50 mm A23187
concentrations (Fig. 6). or not isoflurane was present; (Fig. 12). C20:4 induced a
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Fig. 7. Effect of isoflurane (Iso) on Ca21 io-
nophore A23187 (CaI)-induced deacylation.
Isoflurane significantly increased the extent
of CaI-induced deacylation, affecting C20:4,
total unsaturated, and total saturated fatty
acid pools (abbreviations are in Fig. 2 leg-
end). *P , 0.05; #P , 0.025.
Fig. 8. Effect of isoflurane (Iso) on extent of amphotericin B (AB)
mediated cell death (LDH release). Isoflurane had no independent
Fig. 10. Isoflurane (Iso) effects on the extent of hypoxic or antimycineffect on LDH release. AB, in either a 25 or 50 mg/ml dose, minimally
A (AA)–induced cell death (LDH release). Both hypoxia and AAaffected LDH release. However, in the presence of isoflurane, both
induced marked cell death. When isoflurane was present, a modest, butAB doses induced substantial cell death. *P , 0.01 vs. AB alone (compa-
significant, attenuation of LDH release resulted. *P , 0.005; #P , 0.01.rable doses).
Glycine effects on isoflurane-induced cell death
Control tubules manifested 12% 6 1% LDH release.
High-dose isoflurane (10 ml) caused marked cytotoxicity
(55% 6 8% LDH release; P 5 0.01). The presence
of glycine during the isoflurane challenge completely
abrogated isoflurane-mediated cell death (13% 6 1%
LDH release; NS vs. control incubations).
NBD phosphatidylserine uptake
Control cells demonstrated marked uptake of fluo-
rescent phosphatidylserine (Fig. 13A). Isoflurane pro-Fig. 9. Impact of isoflurane (Iso) on amphotericin B (AB)-induced
ATP decrements. AB (in either 25 or 50 mg/ml doses) and isoflurane foundly diminished this uptake, as illustrated in Figure
each induced modest ATP depressions. However, when present to- 13B. (The employed isoflurane exposure had previously
gether, synergistic ATP depletion resulted.
been demonstrated to cause no cytotoxicity, as reflected
by a lack of LDH release.)
dose-dependent RBC lysis. At each C20:4 concentration
DISCUSSIONtested, the presence of isoflurane increased C20:4-medi-
ated cell lysis. The most dramatic difference was observed Despite their widespread use for over 40 years, the
mechanisms by which fluorinated anesthetics induce an-at the 100 mm C20:4 concentration (76% vs. 37% LDH
release; P , 0.001 with vs. without isoflurane present). esthesia and their concomitant effects on cellular homeo-
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Fig. 11. Chemical anoxia (antimycin A)-
induced deacylation in the presence and ab-
sence of isoflurane (Iso). Antimycin A (AA)
induced substantial deacylation (abbrevia-
tions are in the Fig. 2 legend), a result which
was not significantly altered by the presence
of isoflurane. When these assessments were
repeated in the presence of glycine (to pre-
vent lethal cell injury) isoflurane still did not
alter the extent of antimycin’s deacylation
effect. Symbols are: ( ) control; ( ) anti-
mycin A; ( ) antimycin 1 isoflurane.
[34–36] and because C20:4 inhibits mitochondrial ATP
production [18], increments of FFA can alter the expres-
sion of necrotic tubular cell death. We recently reported
that pharmacologically relevant isoflurane exposures
directly increase renal tubular membrane susceptibility
to sphingomyelinase-mediated sphingomyelin hydrolysis
[12]. In view of these considerations, we have now tested
a corollary hypothesis: Isoflurane sensitizes tubular cell
membranes to PLA2-mediated glycerophospholipid at-
tack. The results obtained strongly support this concept.
Isoflurane, when present alone, induced only trivial fatty
acid elevations (that is, a 0.5 pmol/nmol C20:4 incre-
ment). However, when isoflurane was present during an
Fig. 12. Effect of isoflurane on C20:4–mediated red blood cell (RBC) exogenous PLA2 challenge, a dramatic sensitization tolysis. RBCs were incubated with 50, 100, or 200 mm C20:4 6 isoflurane.
PLA2-mediated deacylation resulted (raising C20:4 byAt each C20:4 concentration tested, isoflurane increased the extent of
RBC lysis (overall, P , 0.01); this was despite the fact that isoflurane, approximately 70 pmol/nmol over values observed with
by itself, exerted no independent cytolytic effect. Hence, these results PLA2 alone). Because the large amount of added PLA2are exactly analogous to those obtained using isolated tubules (see Fig. 4).
undoubtedly trivialized any endogenous PLA2 activity,
these findings strongly suggest that isoflurane does, in-
deed, sensitize membranes to PLA2-mediated attack.
The potential implications of these findings to cell viabil-stasis have remained largely undefined [1, 2]. Neverthe-
ity are underscored by the fact that isoflurane increasedless, it has generally been assumed that they exert their
LDH release and not just FFA levels. In summary, theseactivity via interactions with membrane lipid bilayers.
data support the underlying tenet of this study: Isoflur-This can alter the membrane’s physical characteristics
ane, a prototypic fluorinated anesthetic, can critically(such as its fluidity) [13] and the function of the ion
alter tubular cell injury responses.channels, transporters, and receptors that reside in it
Because isoflurane potentiated both PLA2-mediated[1, 2]. Given these protean influences, a corollary of
deacylation and cytotoxicity, we next tested whetheranesthetic exposure could be perturbed membrane, and
these two events might be mechanistically linked. To-hence cellular susceptibility to energy depletion and
ward this end, PTS were exposed to exogenous C20:4 intoxic attack. This study was undertaken to gain some
the presence and absence of isoflurane. Although iso-insights into this issue.
flurane did not independently alter LDH release, it eitherDuring diverse forms of cell injury, intracellular PLA2s
unmasked, or increased, C20:4’s cytotoxic effects. Theseare activated; they can translocate to the plasma mem-
results are important for at least two reasons: (1) theybrane, and glycerophospholipid deacylation then results
support the concept that isoflurane could potentiate PLA2[15, 16, 18, 23]. This process, possibly coupled with de-
cytotoxicity by increasing the cytotoxic FFA burden; (2)creased mitochondrial fatty acid metabolism, causes dra-
they reiterate that isoflurane can dramatically alter mem-matic fatty acid accumulation within affected cells. Be-
cause FFAs exert detergent effects on cell membranes brane and hence cellular susceptibility to attack. That
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Fig. 13. NBD-phosphatidylserine uptake by cultured human proximal tubule (HK-2) cells. Under control conditions (A) HK-2 cells rapidly
accumulated NBD-phosphatidylserine. However, when the cells were pretreated with isoflurane for 30 minutes, which induced no HK-2 cell death,
there was almost a complete absence of NBD-phosphatidylserine uptake (B; consistent with aminophospholipid translocase inhibition).
isoflurane also sensitized RBCs to C20:4-mediated lysis to either the 35 mm or 50 mm Ca21 ionophore (A23187).
A correlate of this phenomenon was increased FFA ac-indicates that the PTS data are not simply due to a PTS
isolation artifact and that the current findings could have cumulation. That this could be documented prior to the
onset of significant differences in LDH release among thea relatively broad-based biological relevance. For exam-
ple, were isoflurane to alter endothelial cell homeostasis, groups implies that the FFA increments were not simply
nonspecific consequences of tubule cell death. These re-it could impact the hemodynamic changes that are inher-
ent to the anesthetic state [1, 2]. sults are directly relevant to those obtained with exoge-
nous PLA2. They support the concept that isoflurane can,Analogous to phospholipase activation/fatty acid accu-
mulation, cytosolic Ca21 loading is another potential me- indeed, sensitize membranes to PLA2-mediated deacyla-
tion, and they indicate that this phenomenon can be ex-diator of diverse forms of tubule cell attack [37]. Indeed,
recent work by Weinberg, Davis and Venkatachalam pressed when the site of the activated PLA2 is the intracel-
lular, and not simply the extracellular, compartment.indicates that during ATP depletion-mediated tubule in-
jury, Ca21 values as high as 0.1 mm can be achieved In addition to the plasma membrane, the mitochondrion
represents an additional target at which fluorinated anes-[27]. Because cell Ca21 loading can activate intracellular
PLA2s [37], triggering membrane deacylation, we tested thetics might impact renal tubular cell damage. As we
have previously reported, methoxyflurane, sevoflurane,whether isoflurane might predispose to Ca21 overload-
initiated tubular cell death. This was clearly the case be- desflurane, and isoflurane can each induce dose-depen-
dent reductions in tubule ATP production [11]. Thesecause isoflurane potentiated LDH release with exposure
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findings have been linked to fluoride, per se, because though the reason for isoflurane’s seemingly “paradoxi-
cal” impact on tubule responses to hypoxic versus toxicinorganic fluoride, but not ether (a structurally similar
but nonfluorinated agent), reproduced this mitochondrial forms of injury remains unknown, it is by no means
unprecedented. For example, we, as well as others, havesuppressive effect [11]. This study demonstrates the poten-
tial impact of this partial mitochondrial inhibition on the found an identical “paradox” with PLA2 and C20:4 addi-
tions. Whereas both dramatically potentiate nonhypoxicexpression of a superimposed energy depletion state.
When ATP consumption was increased with a Na iono- forms of PTS injury [43], each strikingly abrogates hyp-
oxic cell death [43–45]. Indeed, as isoflurane sensitizesphore, isoflurane sufficiently retarded ATP production
that critical ATP depletion (,90%) developed. The func- to tubular cells to both PLA2 and C20:4, it seems quite
possible that this is the pathway by which isofluranetional significance of this finding is underscored by the
fact that, whereas neither Na ionophore nor isoflurane attenuates hypoxic cell death.
The mechanism by which isoflurane alters plasma mem-alone induced lethal tubular cell injury, when present to-
gether, substantial LDH release resulted. brane responses to tubular injury remains to be defined.
However, of potential interest in this regard is our novelIn addition to retarding ATP production under condi-
tions of increased ATP consumption, an additional way finding that isoflurane can dramatically inhibit phospha-
tidylserine trafficking across the plasma membrane (Fig.that isoflurane might trigger critical energy depletion is by
retarding mitochondrial function when the latter is already 13). This implies inhibition of aminophosphatidyl-trans-
locase function, which is critical for maintenance of nor-in a partially compromised state. In a previous study [18],
we noted that PLA2 can decrease mitochondrial ATP mal transmembrane phospholipid asymmetry [28–30].
When this process is disrupted, constituent phospholip-production by generating toxic amounts of C20:4. Be-
cause isoflurane predisposes to PLA2-mediated deacyla- ids can migrate between the inner and outer membrane
leaflets, giving rise to membrane “flip flop.” As a result,tion, we next questioned whether isoflurane plus C20:4
might induce synergistic ATP depletion by inducing phosphatidylcholine and sphingomyelin may migrate
from the outer to the inner leaflet, whereas the outeroverlapping mitochondrial defects. As demonstrated in
Figure 5, this appears to be the case. Whereas isoflurane leaflet may become relatively enriched with phosphatyl-
ethanolamine and phosphatidylserine, normally innerand C20:4 (or PLA2) each induced modest ATP reduc-
tions, when present together, synergistic ATP depletion leaflet constituents. Because phospholipids have differing
susceptibilities to degradation, membrane reorientation,resulted. It is noteworthy that the mitochondrion is a
critical site of FFA disposal. Hence, if isoflurane and or “flip flop,” could alter cellular susceptibility to attack.
As an example, phosphatidylcholine is more resistant toC20:4 were to inhibit mitochondrial function synergisti-
cally, “a vicious cycle” of mitochondrial suppression and PLA2-mediated deacylation than are phosphatidyletha-
nolamine/serine [22]. Hence, alterations in the expres-further C20:4 accumulation could result.
A compelling issue that emerges from the previously sion of these moieties on the inner versus the outer leaflet
could certainly alter membrane susceptibility to attack.mentioned studies is defining isoflurane’s influence on
tubular responsiveness to hypoxic attack. On the one Were isoflurane to induce plasma membrane “flip flop,”
such a change could also help explain our previous obser-hand, a marked potentiation of hypoxic cell necrosis
might be expected, as isoflurane enhances PLA2, C20:4, vation that fluorinated anesthetics increase sphingomye-
lin hydrolysis [12]. Because a correlate of membraneand Ca21 ionophore toxicity, and it can convert sublethal
ATP depletion (such as that induced by AB) into a “flip flop” may be sphingomyelin movement from the
outer to the inner leaflet, increased exposure to cytosoliclethal ATP depleted state. On the other hand, we have
previously observed that inorganic fluoride can paradox- sphingomyelinases would result. Furthermore, because
ceramide and its secondary product, sphingosine, canically suppress injury when cultured human tubular cells
are subjected to a complete energy deficient state (anti- exert cytotoxic as well as cytoprotective influences [36,
46, 47], these changes could also influence tubular re-mycin A) [5]. Furthermore, fluorinated anesthetics have
been reported to decrease in vivo/in vitro myocardial sponses to attack.
Given that millions of patients are exposed annually[38–40] and cerebral [41] ischemic damage and to attenu-
ate the severity of the glycerol model of ARF [42]. These to fluorinated anesthetics, a compelling clinical question
is whether the presently defined toxic effects of theseobservations imply that fluorinated anesthetics can con-
fer cytoprotective, and not just injurious, effects. To test agents can be minimized, potentially decreasing intraop-
erative tissue damage. Because glycine can prevent, orisoflurane’s impact on hypoxic tubule damage directly,
PTS were challenged with hypoxia or chemical hypoxia mitigate, hypoxic and selected forms of toxic tubule in-
jury [26, 27, 48, 49], we tested whether it might alsofor 15 minutes, and in both instances, isoflurane modestly
decreased cell death. In further contrast to the other attenuate high-dose fluorinated anesthetic-induced cell
death [11]. Indeed, this was the case because glycineforms of PTS injury that were tested, isoflurane did not
increase hypoxia-initiated deacylation reactions. Al- completely prevented high-dose isoflurane-mediated
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13. Pellkofer R, Sandhoff K: Halothane increases membrane fluidityLDH release. This result indicates that fluorinated anes-
and stimulates sphingomyelin degradation by membrane-bound
thetic toxicity is at least amenable to a blockade. If it neutral sphingomyelinase of synaptosomal plasma membranes
from calf brain already at clinical concentrations. J Neurochemwere possible to do this while leaving beneficial anesthe-
34:988–992, 1980tic effects in place, one might conceivably alter anesthetic
14. Mooibroek MJ, Cook HW, Clarke JTR, Spence MS: Catabolism
prescriptions with the goal of decreasing the risk of post- of exogenous and endogenous sphingomyelin and phosphatidyl-
choline by homogenates and subcellular fractions of cultured neu-operative ARF. Clearly, it is premature to suggest that
roblastoma cells: Effects of anesthetics. J Neurochem 44:1551–1558,the current in vitro observations have in vivo relevance.
1985
Nevertheless, these findings, coupled with previous ob- 15. Weinberg JM: The cell biology of ischemic renal injury. Kidney
Int 39:476–500, 1991servations that fluorinated anesthetics can attenuate in
16. Bonventre JV: Mechanisms of ischemic acute renal failure. Kidneyvivo renal and extra-renal tissue damage [38–41], under-
Int 43:1160–1178, 1993
score the potential clinical importance of this area of 17. Zager RA: Pathogenetic mechanisms in nephrotoxic acute renal
failure. Semin Nephrol 17:3–14, 1997investigation.
18. Zager RA, Conrad DS, Burkhart K: Phospholipase A2: A poten-
tially important determinant of adenine nucleotide triphosphate
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